$0.8449
-0.01-1.34%
At close: -
$0.8478
0.002900.34%
After Hours: Jan 31, 6:42 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Seres Therapeutics in recent months.
Browse guidance and forecast on all stocks.